MedTrace Logo

A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head Resurfacing

NCT02405208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2025-12-24

Study results available
· View outcomes & findings →

Summary

This study is designed as a multi-center, nonrandomized, uncontrolled, unblinded, prospective clinical outcomes investigation to evaluate the short, mid and long term performance of the PyroTITAN™ HRA Shoulder prosthesis humeral replacement.

Conditions

Interventions

DEVICE

PyroTITAN HRA

Humeral resurfacing using the PyroTITAN HRA device

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Julie Lankiewicz · Smith & Nephew, Inc.

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Australia
  • France
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02405208 on ClinicalTrials.gov